Discover
KMTS
Kestra Medical Technologies, Ltd.
26.28
2 x 19.70
2 x 33.28
bid
ask
+
0.84
3.30%
2 @ 04:00 PM
26.28 +0.00 (0.00%)
| Ytd | -0.90% | |
| 1y | 65.91% |
25.78
day range
27.84
13.25
52 week range
30.00
| Open | 25.78 | Prev Close | 25.44 | Low | 25.78 | High | 27.84 | Mkt Cap | 1.53B |
| Vol | 752.41K | Avg Vol | 314.38K | EPS | -5.46 | P/E | N/A | Forward P/E | -11.89 |
| Beta | N/A | Short Ratio | 9.88 | Inst. Own | 102.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 21.27 | 200-d Avg | 23.51 | 1yr Est | 27.71 |
| Income Statement | |||
| Total Revenue | 24.55M | ||
| Revenues (USD) | 24.55M | ||
| Cost of Revenue | 11.65M | ||
| Gross Profit | 12.91M | ||
| Operating Expenses | 47.67M | ||
| Research and Development Expense | 4.97M | ||
| Selling, General and Administrative Expense | 42.70M | ||
| Operating Income | -34.76M | ||
| Interest Expense | 1.89M | ||
| Income Tax Expense | 35.00K | ||
| Net Income | -34.17M | ||
| Net Income Common Stock | -34.17M | ||
| Net Income Common Stock (USD) | -34.17M | ||
| Consolidated Income | -34.17M | ||
| Earnings per Basic Share | -0.61 | ||
| Earnings per Basic Share (USD) | -0.61 | ||
| Earnings per Diluted Share | -0.61 | ||
| Earning Before Interest & Taxes (EBIT) | -32.24M | ||
| Earning Before Interest & Taxes (USD) | -32.24M | ||
| Weighted Average Shares | 55.85M | ||
| Weighted Average Shares Diluted | 55.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 293.50M | ||
| Cash and Equivalents (USD) | 293.50M | ||
| Trade and Non-Trade Receivables | 12.71M | ||
| Current Assets | 314.06M | ||
| Property, Plant & Equipment Net | 57.22M | ||
| Total Assets | 379.34M | ||
| Debt Current | 10.00K | ||
| Total Debt | 46.55M | ||
| Current Liabilities | 42.93M | ||
| Debt Non-Current | 46.54M | ||
| Total Liabilities | 91.35M | ||
| Accumulated Retained Earnings (Deficit) | -613.03M | ||
| Shareholders Equity | 287.99M | ||
| Shareholders Equity (USD) | 287.99M | ||
| Assets Non-Current | 65.28M | ||
| Total Debt (USD) | 46.55M | ||
| Inventory | 6.83M | ||
| Liabilities Non-Current | 48.42M | ||
| Trade and Non-Trade Payables | 24.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.11M | ||
| Net Cash Flow from Financing | 149.18M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 115.90M | ||
| Capital Expenditure | -9.92M | ||
| Issuance (Purchase) of Equity Shares | 149.21M | ||
| Net Cash Flow from Investing | -14.92M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -5.00M | ||
| Net Cash Flow from Operations | -18.37M | ||
| Share Based Compensation | 10.11M | ||